PHIBRO ANIMAL HEALTH CORP (PAHC) Q4 2025 10-Q Quarterly Report
PHIBRO ANIMAL HEALTH CORP (PAHC) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Feb 4, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
PHIBRO ANIMAL HEALTH CORP Q4 2025 10-Q Analysis
Risk Factors
- • No new or materially changed risk factors reported since most recent 10-K filing
- • Regulatory compliance risk from evolving animal health product standards remains material, potentially impacting product approvals
- • Operational risk tied to supply chain disruptions noted, with possible near-term delays affecting production timelines
- • Market risk from increased competition in animal health sector, pressure on pricing and market share persistence
- • Financial risk related to working capital management and ensuring liquidity for ongoing operations amid uncertain market conditions
Get deeper insights on PHIBRO ANIMAL HEALTH CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.